Search
The Newsletter
The Principals
Reports
Conferences
Databases
Custom Research
Contact Us
Home
 

Online Report Subscribers, Click Here

Pricing and Ordering Information

 

U.S. Markets for Interventional Technologies for the Management of Peripheral Vascular Disorders
Report #A248
- January 2014
273 Pages – 62 Exhibits – 18 Company Profiles


Peripheral vascular disease (PVD) refers to those conditions that affect the vessels carrying blood to and from the extremities as well as the tissues and organs of the abdominal and pelvic cavities. The most commonly diagnosed form of PVD is plaque-related peripheral artery disease; among the other types of PVD are chronic venous insufficiency, deep vein thrombosis, and pulmonary embolism.

In 2012, approximately 3.8 million interventional procedures for the diagnosis and treatment of PVD were performed in the United States (U.S.), generating an estimated $1.67 billion in corresponding product sales. The number of diagnostic and therapeutic interventions for PVD management is expected to increase at a compound annual rate of 2.0% during the forecast period covered by this report, reaching nearly 4.2 million in the year 2013. Sales of products to perform these interventional procedures are projected to increase at a compound annual rate of 6.0% during the forecast period covered by this report, reaching an estimated $2.2 billion in the year 2013.

This dynamic, new report from Medtech Insight includes analyses of products, current and forecast markets, competitors, and opportunities in the U.S. interventional peripheral vascular disease management arena.

Covered topics in this report include angiography devices; catheter-directed thrombolysis products; drug-eluting balloon systems; cryotherapy products; endovascular embolization products; intravascular ultrasound systems; mechanical atherectomy systems; thrombectomy products; noninvasive peripheral vascular disease treatments; peripheral transluminal angioplasty devices; surgical/endoscopic peripheral vascular disease treatments; vascular puncture closure devices; and vena cava filters, among others.

Ordering Information

Title

Report# Publication
Date
List Price

U.S. Markets for Interventional Technologies for the Management of Peripheral Vascular Disorders

A248

January 2014

$4,750

Order Online:
Single User only (Please call for corporate subscription pricing)
PDF Only

Print versions of Reports are available upon request for an additional fee.

Methodology

Reports are produced exclusively by Medtech Insight, through extensive primary and secondary research among the clinicians, researchers, and competitors in the marketplace, and draw upon the industry expertise of a network of industry insiders. Medtech Insight exhaustively corroborates the data as a baseline for completing forward-looking analysis and providing insight into product, technology and market evolution.

 

TABLE OF CONTENTS

 

Executive Summary

i.      Interventional Peripheral Vascular Disease Diagnostic Products Market

a.     Angiography

b.     Intravascular Ultrasound

ii.     Interventional Peripheral Vascular Disease Treatment Products Market

a.     Percutaneous Transluminal Angioplasty

b.     Catheter-Directed Thrombolysis

c.     Mechanical Atherectomy

d.     Endovascular Embolization

e.     Thrombectomy

f.      Vena Cava Filter Placement

g.     Vascular Puncture Hemostasis

h.     Cryotherapy

iii.         Methodology

 

Exhibit ES-1:    Interventional Peripheral Vascular Disease Management, Combined Procedure Volumes Forecast, 2012-2017

Exhibit ES-2:    Interventional Peripheral Vascular Disease Management Products, Combined Market Forecast, 2012-2017

Exhibit ES-3:    Interventional Peripheral Vascular Disease Management Products, Combined Market Forecast,  by Segment 2012-2017

Exhibit ES-4:    Angiography Devices for Peripheral Vascular Disease Diagnostics, Market Forecast, 2012-2017

Exhibit ES-5:    Intravascular Ultrasound Catheters, Market Forecast, 2012-2017

Exhibit ES-6:    Percutaneous Transluminal Angioplasty Devices, Market Forecast, 2012-2017

Exhibit ES-7:    Catheter-Directed Thrombolysis Systems, Market Forecast, 2012-2017

Exhibit ES-8:    Mechanical Atherectomy Systems, Market Forecast, 2012-2017

Exhibit ES-9:    Endovascular Embolization Products, Market Forecast, 2012-2017

Exhibit ES-10:  Thrombectomy Systems, Market Forecast, 2012-2017

Exhibit ES-11:  Vena Cava Filter Systems, Market Forecast, 2012-2017

Exhibit ES-12:  Vascular Puncture Closure Systems, Market Forecast, 2012-2017

Exhibit ES-13:  Endovascular Cryotherapy Systems, Market Forecast, 2012-2017

 

1. PERIPHERAL VASCULAR DISEASE OVERVIEW

1.1 Anatomy and Physiology of the Circulatory System

1.2 Types of Peripheral Vascular Disease

1.2.1 Peripheral Artery Disease

1.2.1.1 Etiology

1.2.1.2 Epidemiology

1.2.2 Aneurysm

1.2.2.1 Etiology

1.2.2.2 Epidemiology

1.2.3 Deep Vein Thrombosis and Pulmonary Embolism

1.2.3.1 Etiology

1.2.3.2 Epidemiology

1.2.4 Chronic Venous Insufficiency

1.2.4.1 Etiology

1.2.4.2 Epidemiology

 

Exhibit 1-1:      2013, Peripheral Artery Disease, Facts and Figures

Exhibit 1-2:      2013, Aortic Aneurysm, Facts and Figures

Exhibit 1-3:      2013, Deep Vein Thrombosis, Facts and Figures

Exhibit 1-4:      Classification of Chronic Venous Insufficiency

Exhibit 1-5:      2013, Chronic Venous Insufficiency, Facts and Figures

 

2. INTERVENTIONAL PERIPHERAL VASCULAR DISEASE DIAGNOSTIC PRODUCTS MARKET

2.1 Noninvasive Peripheral Vascular Disease Diagnostics

2.1.1 Ankle/Brachial Index

2.1.2 Exercise Tolerance Testing

2.1.3 Imaging Methods

2.1.3.1 Computed Tomography

2.1.3.2 Magnetic Resonance Imaging

2.1.3.3 Diagnostic Ultrasound Imaging

2.1.4 Photoplethysmography and Air Plethysmography

2.2 Interventional Peripheral Vascular Disease Diagnostics, Market Analysis

2.2.1 Angiography

2.2.1.1 Types

2.2.1.1.1 Peripheral Arterial Angiography

2.2.1.1.2 Peripheral Venous Angiography

2.2.1.1.3 Ascending and Descending Venography

2.2.1.1.4 Venographic Applications for Deep Vein Thrombosis in Lower and Upper Extremities

2.2.1.2 Procedures/Technologies

2.2.1.3 Products

2.2.1.4 Market Forecast

2.2.1.5 Competitors

2.2.2 Intravascular Ultrasound

2.2.2.1 Procedures/Technologies

2.2.2.2 Products

2.2.2.3 Market Forecast

2.2.2.4 Competitors

 

Exhibit 2-1:      Interventional Peripheral Vascular Disease Diagnosis, Combined Procedure Volumes Forecast, 2012-2017

Exhibit 2-2:      Interventional Peripheral Vascular Disease Diagnostic Products, Combined Market Forecast, 2012-2017

Exhibit 2-3:      Peripheral Angiography, Procedure Volumes Forecast, 2012-2017

Exhibit 2-4:      2013, Selected Angiography Catheters

Exhibit 2-5:      2013, Selected Diagnostic Guidewires

Exhibit 2-6:      2013, Selected Introducers/Sheaths

Exhibit 2-7:      Angiography Devices for Peripheral Vascular Disease Diagnostics, Market Forecast, 2012-2017

Exhibit 2-8:      2012, Market for Angiography Devices for Peripheral Vascular Disease Diagnostics, Share by Supplier

Exhibit 2-9:      Intravascular Ultrasound, Procedure Volumes Forecast, 2012-2017

Exhibit 2-10:    2013, Selected Intravascular Ultrasound Catheters and Systems

Exhibit 2-11:    Intravascular Ultrasound Products, Market Forecast, 2012-2017

Exhibit 2-12:    2012, Intravascular Ultrasound Products Market, Share by Supplier

 

3. INTERVENTIONAL PERIPHERAL VASCULAR DISEASE TREATMENT PRODUCTS MARKET

3.1 Noninvasive Peripheral Vascular Disease Treatments

3.2 Surgical/Endoscopic Peripheral Vascular Disease Treatments

3.2.1 Peripheral Artery Surgery

3.2.1.1 Aortofemoral Bypass Graft Surgery

3.2.1.2 Distal Tibial-Peroneal Vascular Reconstruction

3.2.1.3 Femoropopliteal Bypass Graft Surgery

3.2.2 Thromboendarterectomy

3.2.3 Chronic Venous Insufficiency and Venous Ulceration Treatments

3.2.3.1 Deep Vein Reconstruction

3.2.3.2 Open Subfascial Perforator Surgery

3.2.3.3 Sclerotherapy

3.2.3.4 Skin Grafting

3.2.3.5 Subfascial Endoscopic Perforator Surgery

3.2.3.6 Superficial Vein Stripping

3.3 Interventional Peripheral Vascular Disease Treatments, Market Analysis

3.3.1 Percutaneous Transluminal Angioplasty

3.3.1.1 Procedures/Technologies

3.3.1.2 Products

3.3.1.2.1 Balloon Catheters

3.3.1.2.2 Guiding Catheters

3.3.1.2.3 Guidewires

3.3.1.2.4 Introducers/Sheaths

3.3.1.2.5 Accessories

3.3.1.2 Market Forecast

3.3.1.3 Competitors

3.3.2 Catheter-Directed Thrombolysis

3.3.2.1 Procedures/Technologies

3.3.2.2 Products

3.3.2.3 Market Forecast

3.3.2.4 Competitors

3.3.3 Mechanical Atherectomy

3.3.3.1 Procedures/Technologies

3.3.3.2 Products

3.3.3.3 Market Forecast

3.3.3.4 Competitors

3.3.4 Endovascular Embolization

3.3.4.1 Procedures/Technologies

3.3.4.2 Products

3.3.4.3 Market Forecast

3.3.4.4 Competitors

3.3.5 Thrombectomy

3.3.5.1 Procedures/Technologies

3.3.5.2 Products

3.3.5.3 Market Forecast

3.3.5.4 Competitors

3.3.6 Vena Cava Filter Placement

3.3.6.1 Procedures/Technologies

3.3.6.2 Products

3.3.6.3 Market Forecast

3.3.6.4 Competitors

3.3.7 Vascular Puncture Hemostasis Tools and Techniques

3.3.7.1 Procedures/Technologies

3.3.7.2 Products

3.3.7.3 Market Forecast

3.3.7.4 Competitors

3.3.8 Cryotherapy

3.3.8.1 Procedures/Technologies

3.3.8.2 Products

3.3.8.3 Market Forecast

 

Exhibit 3-1:      Interventional Peripheral Vascular Disease Treatment, Combined Procedure Volumes Forecast, 2012-2017

Exhibit 3-2:      Interventional Peripheral Vascular Disease Treatment Products, Combined Market Forecast, 2012-2017

Exhibit 3-3:      Percutaneous Transluminal Angioplasty, Procedure Volumes Forecast, 2012-2017

Exhibit 3-4:      2013, Selected Percutaneous Transluminal Angioplasty Balloon Catheters

Exhibit 3-5:      Percutaneous Transluminal Angioplasty Devices, Market Forecast, 2012-2017

Exhibit 3-6:      2012, Percutaneous Transluminal Angioplasty Devices Market, Share by Supplier

Exhibit 3-7:      Catheter-Directed Thrombolysis, Procedure Volumes Forecast, 2012-2017

Exhibit 3-8:      2013, Selected Catheter-Directed Thrombolysis Systems

Exhibit 3-9:      Catheter-Directed Thrombolysis Systems,  Market Forecast, 2012-2017

Exhibit 3-10:    2012, Catheter-Directed Thrombolysis Systems Market, Share by Supplier

Exhibit 3-11:    Mechanical Atherectomy, Procedure Volumes Forecast, 2012-2017

Exhibit 3-12:    2013, Selected Mechanical Atherectomy Systems

Exhibit 3-13:    Mechanical Atherectomy Systems, Market Forecast, 2012-2017

Exhibit 3-14:    2012, Mechanical Atherectomy Systems, Share by Supplier

Exhibit 3-15:    Endovascular Embolization, Procedure Volumes Forecast, 2012-2017

Exhibit 3-16:    2013, Selected Endovascular Embolization Products

Exhibit 3-17:    Endovascular Embolization Products, Market Forecast, 2012-2017

Exhibit 3-18:    2012, Endovascular Embolization Products Market, Share by Supplier

Exhibit 3-19:    Thrombectomy, Procedure Volumes Forecast, 2012-2017

Exhibit 3-20:    2013, Selected Thrombectomy Systems

Exhibit 3-21:    Thrombectomy, Market Forecast, 2012-2017

Exhibit 3-22:    2012, Thrombectomy Systems Market, Share by Supplier

Exhibit 3-23:    Vena Cava Filter Placement, Procedure Volumes Forecast, 2012-2017

Exhibit 3-24:    2013, Selected Vena Cava Filter Systems

Exhibit 3-25:    Vena Cava Filter Systems, Market Forecast, 2012-2017

Exhibit 3-26:    2012, Vena Cava Filter Systems Market, Share by Supplier

Exhibit 3-27:    Vascular Puncture Closure Systems, Procedure Volumes Forecast, 2012-2017

Exhibit 3-28:    2013, Selected Vascular Puncture Closure Systems

Exhibit 3-29:    Vascular Puncture Closure Systems, Market Forecast, 2012-2017

Exhibit 3-30:    2012, Vascular Puncture Closure Systems Market, Share by Supplier

Exhibit 3-31:    Endovascular Cryotherapy, Procedure Volumes Forecast, 2012-2017

Exhibit 3-32:    Endovascular Cryotherapy Systems, Market Forecast, 2012-2017

 

4. COMPANY PROFILES

4.1       Abbott Laboratories

4.2       AccessClosure, Inc.

4.3       AngioDynamics, Inc.

4.4       Arrow International/Teleflex, Inc.

4.5       C.R. Bard, Inc.

4.6       Boston Scientific Corporation

4.7       B. Braun Melsungen AG

4.8       Cardiovascular Systems, Inc.

4.9       Cardiva Medical, Inc.

4.10     Cook Medical/Cook Group

4.11     Cordis Corporation/Johnson & Johnson

4.12     Covidien

4.13     MEDRAD, Inc./Bayer HealthCare/Bayer Group

4.14     Merit Medical Systems, Inc.

4.15     Spectranetics Corporation

4.16     St. Jude Medical, Inc.

4.17     Terumo Interventional Systems/Terumo Corporation

4.18     Volcano Corporation

 

APPENDIX:  COMPANY LISTING

 

To order reports or obtain information about special pre-publication offers from within the U.S., contact custcare@informa.com. You can also call 1.908.748.1221 (or toll-free within the U.S. at 1.888.670.8900) or fax 1.646.666.9878.

 

The Newsletter | The Principals | Reports | Conferences | Physician Surveys | Consulting | Contact Us | Home